{"disease":{"id":"clostridoides-difficile-associated-disease","name":"clostridoides difficile associated disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05805826","title":"To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":936,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT06979609","title":"Secondary Prevention of Clostridioides Difficile Using Vancomycin","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"McGill University Health Centre/Research Institute of the McGill University Health Centre","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}